Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs STLD✓SelectedUSD · STLDMRNA vs STLD performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs STLD

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-31.0%
STLD return
+246.0%
Excess return
-277.0%
Maximum drawdown
-93.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioSTLDExcessAlpha
1D-2.2%-5.6%+3.5%-1.3%
7D-12.7%-10.2%-2.5%-11.3%
30D-20.7%-16.9%-3.7%-18.5%
3M+46.3%-5.7%+52.0%+47.9%
6M+305.2%-9.4%+314.6%+298.3%
YTD+561.2%+22.5%+538.7%+484.2%
1Y+772.1%+36.0%+736.1%+644.2%
3Y+147.0%+91.7%+55.3%+86.8%
All-31.0%+246.0%-277.0%-57.6%

Cumulative growth

Daily Returns

Daily percentage return beside STLD.

Daily Out/Under-Performance

Portfolio return minus STLD return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × STLD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded STLD wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling